Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hesham M Amin

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Blood|May 24, 2007
Pathobiology of ALK+ anaplastic large-cell lymphomaHesham M Amin, Raymond Lai
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 24, 2006
Jak3 contributes to the activation of ALK and Stat3 in ALK(+) anaplastic large cell lymphomaHesham M Amin, Quan Lin, Raymond Lai
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2014
Leukemic phase of ALK(+) anaplastic large-cell lymphoma, small-cell variant: clinicopathologic pitfalls of a rare entityChi Young Ok, Sa A Wang, Hesham M Amin
Biochemical Pharmacology|July 19, 2005
Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphomaShishir Shishodia, Hesham M Amin, Raymond Lai, et al.
Leukemia & Lymphoma|December 30, 2009
Treatment of aggressive systemic mastocytosis with daclizumabAlfonso Quintás-Cardama, Hesham M Amin, Hagop Kantarjian, et al.
American Journal of Clinical Pathology|March 4, 2005
Postsplenectomy cytomegaloviral mononucleosis: marked lymphocytosis, TCRgamma gene rearrangements, and impaired IgM responseXiang Y Han, Pei Lin, Hesham M Amin, et al.
The American Journal of Surgical Pathology|December 28, 2002
Dissolution of the lymphoid follicle is a feature of the HHV8+ variant of plasma cell Castleman's diseaseHesham M Amin, L Jeffrey Medeiros, John T Manning, et al.
British Journal of Haematology|August 31, 2006
JSI-124 (cucurbitacin I) inhibits Janus kinase-3/signal transducer and activator of transcription-3 signalling, downregulates nucleophosmin-anaplastic lymphoma kinase (ALK), and induces apoptosis in ALK-positive anaplastic large cell lymphoma cellsXinzhe Shi, Bevin Franko, Christine Frantz, et al.
American Journal of Hematology|August 10, 2007
Granulocytic sarcoma with massive scalp involvementAlfonso Quintás-Cardama, Antoine J Harb, Hesham M Amin, et al.
Neoplasia (New York, N.Y.)|October 18, 2015
SUMOylation Confers Posttranslational Stability on NPM-ALK Oncogenic ProteinDeeksha Vishwamitra, Choladda V Curry, Ping Shi, et al.
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Blood|May 24, 2007
Pathobiology of ALK+ anaplastic large-cell lymphomaHesham M Amin, Raymond Lai
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 24, 2006
Jak3 contributes to the activation of ALK and Stat3 in ALK(+) anaplastic large cell lymphomaHesham M Amin, Quan Lin, Raymond Lai
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2014
Leukemic phase of ALK(+) anaplastic large-cell lymphoma, small-cell variant: clinicopathologic pitfalls of a rare entityChi Young Ok, Sa A Wang, Hesham M Amin
Biochemical Pharmacology|July 19, 2005
Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphomaShishir Shishodia, Hesham M Amin, Raymond Lai, et al.
Leukemia & Lymphoma|December 30, 2009
Treatment of aggressive systemic mastocytosis with daclizumabAlfonso Quintás-Cardama, Hesham M Amin, Hagop Kantarjian, et al.
American Journal of Clinical Pathology|March 4, 2005
Postsplenectomy cytomegaloviral mononucleosis: marked lymphocytosis, TCRgamma gene rearrangements, and impaired IgM responseXiang Y Han, Pei Lin, Hesham M Amin, et al.
The American Journal of Surgical Pathology|December 28, 2002
Dissolution of the lymphoid follicle is a feature of the HHV8+ variant of plasma cell Castleman's diseaseHesham M Amin, L Jeffrey Medeiros, John T Manning, et al.
British Journal of Haematology|August 31, 2006
JSI-124 (cucurbitacin I) inhibits Janus kinase-3/signal transducer and activator of transcription-3 signalling, downregulates nucleophosmin-anaplastic lymphoma kinase (ALK), and induces apoptosis in ALK-positive anaplastic large cell lymphoma cellsXinzhe Shi, Bevin Franko, Christine Frantz, et al.
American Journal of Hematology|August 10, 2007
Granulocytic sarcoma with massive scalp involvementAlfonso Quintás-Cardama, Antoine J Harb, Hesham M Amin, et al.
Neoplasia (New York, N.Y.)|October 18, 2015
SUMOylation Confers Posttranslational Stability on NPM-ALK Oncogenic ProteinDeeksha Vishwamitra, Choladda V Curry, Ping Shi, et al.
Pageof 12